Biochemical Effect of Nepeta Septemcrenata Growing in South Sinai, Egypt

Abd El-Raouf A. Moustafa1*, HamdyAbd El-Azeem2, Mohamed A. Omran3, Sawsan A. M. Nasr4, Ismail M. Abdel-Nabi3 and Zakaria A. Teleb4

1Botany Department, Faculty of Science, Suez Canal University, Egypt

2Chemistry Department, Faculty of Science, Suez Canal University, Egypt

3Zoology Department faculty of Science, Suez Canal University, Egypt

4Biochemistry and Molecular Biology National Organization for Drug Control and Research

*Corresponding Author:
Abd El-Raouf A. Moustafa
Botany Department
Faculty of Science
Suez Canal University, Egypt
E-mail: raoufmoustafa2@hotmail.com
Visit for more related articles at American Journal of Ethnomedicine

Abstract

The present study aims to at investigate the effect of ethanolic extract of Nepetaseptemcrenata on lipid peroxidation and antioxidant defenses, the activities of three lysosmal acid hydrolases and the total protein, DNA and RNA contaent and Hepatic and kidney functions. In this study, three main tests were investigated including; Pharmachological effect of the plant extraction, Biochemical effect of the ethanolic extract and Effect of Nepetaseptemcrenata ethanolic extract on liver lysosomal enzymes, total protein, DNA and RNA. The results reviewed that antipyretic effect is the decreasing of the temperature of the hyperthermic rats, theethanolic extract of Nepetaseptemcenata which given interperotential to rats with inflamed paw in a dose of (1/5 LD50 & 1/10 LD50) significantly decreased the thickness of the inflamed rats' paw as compared with the control group and standard group after 6 hours. The ethanolic extract of Nepetaseptemcrenata in a dose of 1.1 and 50.5 mg/kg, induced protection against writhing response andreaches its maximum effect in a dose of 1.1 mg/kg. In theAntibacterial activity the investigation of antimicrobial activities of Nepetaseptemcrenataextract revealed that it has no activity against S. aureus and a very weak antiseptic action against E. coli. Finally, Nepetaseptemcrenata hasmuch medicinal prosperity.

Keywords

Nepetaseptemcenata, Antioxidant, Egypt.

Introduction

Nepeta is one of the most important genera of lamiaceae family with regard to the number of its species. Some species of this genus are important medicinal plants and their extracts have been used for medicinal purposes [1]. Some species of Nepeta germs are utilized in folk medicine for treatment of contusions, rheumatic pains, fever, cutaneous eruption and some species are used for their anti-inflammatory properties [2]. Nepeta plants were prepared as tea and used in traditional medicine as anthelmintics, febrifuges, expectorants and to treat bronchitis, bites as well as stings of scorpions [3].

Nepetaseptemcrenata is an erect slender plant with branches at base leaves are oppositely alternated, ovate with crenate or slightly dentate margins. This plant is found in Saint Catherine, Sinai, Egypt [4]. Nepetaseptemcrenata known to be used by the native Bedouins in folk medicine as antipyretic, sedative, cardiotonic, eye wash and as a gargle in sore throat [5]. An isopimarance type diterpence and 7-omethyl apigenin were isolated from the ethanolic extract of Nepetaseptemcernata herb [6,5] investigated the chemical constituents of Nepetaseptemcrenata and [7] analyzed the volatile oil of the same plant species [8]. Reported that the lactone- free hot water extract of catnip (Nepetacatrina) causes a significant decrease in the wakefulness and an increase in sleep behavior, particularly deep sleep. A few members of genus Nepetaare reported to posses biological activities especially reduction of serum lipids and inflammatory effects [6].

Nepetais used in traditional medicine as laxative; to treat dysentery, kidney and liver diseases and teeth troubles [9]. Two methods for the preparation of an oral liquid used in traditional Chinese medicine called Jingfang that contains Nepetacataria species [10,11,2] found that Nepetahas antiinflammatory and analgesic activities respectively.[2] Reported the use of Nepeta in folk medicine for treatment of contusions, rheumatic pains, fever, and coetaneous eruptions. The main objects of this present study is:1-Biochemical trail to evaluate the effect of the ethanolic extract of the plant on: Lipid peroxidation and antioxidant defenses, Hepatic and kidney functions and the activities of three lysosmal acid hydrolases and the total protein, DNA and RNA content.

MATERIAL AND METHODS

Pharmacological effect of the plant extraction

This experiment was undertaken to determine the analgesic, antipyretic and antiinflammatory activities of the ethanolic extract of Nepetaseptemecrenata. Mice were used to measure the analgesic activity, whereas rats were selected to measure the antipyretic and anti-inflammatory activities of the extract. Animals of these experiments were exposed to the ethanolic extract in doses equal to 101 mg/kg (1/10 LD50) & 50.5 mg/kg (1/20 LD50) for mice and 101 mg/kg (1/5 LD50) & 50.5 mg/kg (1/20 LD50) &50.5 mg/kg (1/10 LD50) for rats. Thus several test activities have been done upon those animals: Analgesic Activity (Acetic acid induced writhing test), antipyretic activity, anti-inflammatory activity and antimicrobial activity.

Biochemical effect of the ethanolic extract

Sample of blood were collected using the orbital sinus technique (Sanford, 1954) after 2, 4, 8, 16 and 24 hours of treatments for determining the following parameters: Lipid peroxidation as malondialdehyde content in the blood plasma, Glutathione content in blood, Catalase activity in blood, Cu/Zn-SOD activity in blood, Plasma Total antioxidant capacity, Liver function tests: ALT& AST and Gamma GT activities in plasma and Kidney function tests: Creatinine and Urea content in plasma. The method used for estimation of Cu/Zn superoxide dismutase activity in blood was described by [12] and [13].

Effect of Nepetaseptemcrenata ethanolic extract on liver lysosomal enzymes, total protein, DNA and RNA.

First preparation of liver lysosomal fraction, in which the livers of all animals were immediately removed after sacrificing, whole liver samples were perfused in suit with 0.025 M in ice-cold sucrose buffer (pH 7.4) and then homogenized for 10 minutes by electric homogenizer and centrifuged at 2500 rpm in a Beckman refrigerating ultracentrifuge (Model J2-21) for 15 minutes [14,15]. Secondly, preparation of the total lysosomal enzymes in which the solutions were freezed and thawed for three successive times to rupture the lysosmal membranes; centrifugation was done at 19.000 rpm for 20 minutes at 4°C. The supernatant was separated in aliquota and kept at -20°C for determination of lysosomal Acid phosphtase (ACP), β-galctosida (GAL) and β-N-acetyl-D-glucosaminidase (β-NAG) enzyme activities. Third, determination of lysosomal acid hydrolyses activities in which the activities of ACP, β-GAL and β- NAG were carried out according to the method described by [16]. Fourth, the fraction and extraction of intercellular components protein, DNA and RNA of liver cells, the modified procedure of [17] was employed as following: (a) Lipid extraction and (b) Protein extraction (c) RNA extraction (d) DNA extraction. Fifth, determination of total proteins was carried out by the method of [18]. Sixth, quantitative determination of RNA as the RNA content was measured colourimetrically by the modified orcinol procedure. Seventh, quantitative determination of DNA, the DNA content was measured following the diphenylamine procedure described by [19].

Statistical analysis

According to the mathematical principles described by Field (2000) all the data of control and treated groups for both(1/5 LD50& 1/10 LD50) were expresses as mean value± standard error. Student unpaired t- test was used to explain variation between control group and each treated group (each time of treatment) in all parameters. Also the results were analyzed by One-way analysis of (ANOVA test) followed by Tukey-Krameis [20].

RESULTS

Acute toxicity and LD50

After interperitoneal administration of ethanolic extract of Nepetaseptemcrenata in mice, (Up-down method) LD50 was found to be 1009.58 mg/kg body weight for mice and 504.79 mg/kg for rats.

Pharmacological screening of Nepetasetemcrenata

(a) The antipyretic effect of Nepetaseptemcrenata

Antipyretic effect is the decreasing of the temperature of the hyperthermic rats. The results of the antipyretic effects of the tested ethanolic extract (1/5 and 1/10 of Nepetaseptemcrenata were shown in tables (1 and 2). From the tables it was concluded that alcoholic extract of N. septemcrenta when given interaperiotenal to the included hyperthermeric rats in both, does produced the antipyretic effect as shown by decrease in body temperature, when compared to negative and positive control.

Table 1: Antipyretic effect of ethanolic extract of Nepetaseptemcrenata (1/5 LD50) in rats

Treatments Temperature
Before
injection
Fever After 30
min
After 60
min
After 120 min After 180
min
After 240
min
Yeast extract 36.5±0.071 37.16±0.154 37.22±0.16 37.32±0.195 37.36±0.204 37.3±0.232 37.24±0.22
Antipyretic
drug(Aspegic)
36.64±.051 38.02±0.32* 37.68±0.28 37.46±0.273 37.04±0.133 36.76±0.103 36.5±0.123
Plant ethanolic extract(1/5 LD50) 36.5±0.141 36.6±0.141 36.6±0.192 36.28±.211* 36.26±0.258** 36.46±0.24* 36.7±0.259

Table 2: Antipyretic effect of extra of Nepetaseptemcrenata (1/10 LD50) in rat

Treatments Temperature
Before
injection
Fever After 30
min
After 60 min After 120 min After 180
min
After 240
min
Yeast extract 36.5±0.071 37.16±0.154 37.32±0.159 37.32±0.195 37.36±0.204 37.3±0.232 37.24±0.216
Antipyretic drug(Aspegic) 36.64±0.051 38.02±0.318* 37.68±0.281 37.46±0.273 37.04±0.133 36.76±0.103 36.5*±0.123
Plant ethanolic extract(1/5
LD50)
36.5±0.126 37.5±0.217 37.26±0.196 36.26±0.221* 36.34±0.225** 36.82±0.168* 37.24±0.140

(b) The anti-inflammatory effect of Nepetaseptemecrenata

The results of the anti-inflammatory effect of the plant extract are shown in table (3). From this table it's evident that the ethanolic extract of Nepetaseptemcenata which was given interperotential to rats with inflamed paw in a dose of (1/5 LD50& 1/10 LD50) significantly decreased the thickness of the inflamed rats' paw as compared with the control group and standard group after6 hours.

Table 3: Anti-inflammatory effect ethanolic extract of Nepetaseptemcrenata (1/5 LD50) & (1/10LD50)

Group Thickness of paw in mm after (hrs)
Before yeast 4h. after yeast 3h.after
treatment
6h.after
treatment
Control 4.26±0.098 8.46±0.582 8.64±o,0.520 8.62±o.548
Inflammatory Drug
(Diclofenac Sodium)
4.22±.0735 8.82±0.269 6.66±0.309** 6.6**±0.342
Plant Ethanolic
Extract (1/5 LD50)
4.09±.0678 8.875±0.401 7.48±0.22 7.08±0.146*
Control 4.26±0.098 8.46±0.582 8.64±o,0.520 8.62±o.548
Inflammatory Drug
(Diclofenac Sodium)
4.22±.0735 8.82±0.269 6.66±0.309** 6.6**±0.342
Plant ethanolic
extract (1/10 LD50)
4.09±.0678 8.875±0.401 7.48±0.22 7.08±0.146*

(c) The analgestic Effect of Nepetaseptemcrenata

The results of analgesic effect are shown in table (4). From the table we can conclude that, the ethanolic extract of Nepetaseptemcrenata in a dose of 101 and 50.5 mg/kg b.wt. induced protection against writhing response, which reach its maximum effect in a dose of 1.1 mg/kg.

Table 4: Analgesic activity of ethanolic extract ofNepetaseptemcrenata in mice using writhing technique

Treatment Writhing response(No/20 min)
Control 21.2±5.4
Plant ethanolic extract(1/10 LD10) 2.4±0.678**
Plant ethanolic extract(1/20LD50) 8.2±1.068**

Antibacterial activity

Investigation of antimicrobial activities of Nepetaseptemcrenata extract revealed that it has no activity against S. aureus and a very weak antiseptic action against E. coli. The results of antibacterial effect are shown in table (5), which shows that Nepeta extract has no activity against S.aureusand very weak antiseptic action against E. coli at 100 mg/ml.

Table 5: Antibacterial activity of the ethanolic extract of Nepetaseptemcrenata

Microorganism Ethanolic extract Standard
(ref. 10 ug)
10 ug 100ug 1mg 100mg ++
Staphylococcus 00 00 00 00
S.aureus ++
E. coi 00 00 00 00

D-Biochemical study

I-lipid peroxidation

The effect of interperitoneal injection of ethanolic extract of N. septemcrenataon lipid peroxidation content (μmol MDA/L) of rat is presented in table (6) and illustrated graphically.

Table 6: Effect of interperitoneal injection of ethanolic extract of Nepetaseptemcrenatawith two doses (1/5 LD50& 1/10 LD50) on plasma lipid peroxidation content (µmol MDA/L) of rat.

Time period Control Treatment
1/5 LD50 % of change 1/10 LD50 % of change
2hours 0.365±0.01a 0.314±0.03 -13.97 0.334±0.01 -8.49
4hours 0.270±0.01* -26.03 0.358±0.01* -1.91
8hours 0.267±0.02* -26.85 0.249±0.02* -31.78
16hours 0.288±0.03 -21.10 0.341±0.01 -6.57
24hours 0.357±0.01* -2.19 0.264±0.019* -27.67

The results indicated that, in the first treated dose (1/5LD50) there were significant decreases in plasma lipid peroxidation content with percent of changes equal to 26.03% and 26.85% with respect to the control group after 4 and 8 hours respectively, wheres, non-significant decreases were recorded after 2, 16, and 24 hours. One way- ANOVA between the control and the five treated group (2,4, 8, 16 and 24 hours) revealed a highly significant difference (F1,4=5.299, p< 0.001) in lipid peroxidation content. In the second treated dose (1/10 LD50), significant decreases were noticed in plasma lipid peroxidation content with percent of changes equal to 31.78% and 27.67% with respect to the control group after 8 and 24 hours respectively. However, non-significant decreases were recorded after 2, 4 and 16 hours respectively. In addition, a highly significant difference in lipid peroxidation content was observed between the control and the five treated groups (2, 4, 16 and 24 hours) using oneway ANOVA (F1,4=6.052, P< 0.0001). The data also showed significant differences between the two treated doses at the time interval of 4 and 24 hours. Blood glutathione (GSH) content, the effect of interpretational injection of ethanolic extract of N.septemcrenata on blood glutathione (GSH) content (mg/dl) of rat is presented in table (7). The results indicated that the first treated dose (1/5LD50) showed significant increases in blood glutathione content with percent of changes equal to 86.52% and 21.92% when compared with the control group after 2 and 16 hours of treatment respectively. The results showed also nonsignificant increase in this group after 4, 8 and 24 hours of treatment. Highly significant differences in blood glutathione content were observed between the control and the five treated groups (2, 4, 8, 16 and 24 hours) using one-way ANOVA (f14= 314.44, p<0.001). Blood Catalase activity, the effect of interpretational injection of ethanolic extract of N.septemcrenata on blood catalase activity (μ/ml) of rat is presented in table (8). Blood Cu/Zn Superoxide dismutase (SOD) activity, the effect of interpretational injection of ethanolic extract of N. septemcrenata on blood superoxide dismutase activity (μ/ml blood) of rat is presented in table (9). Plasma total antioxidant Capacity (TAC), the effect of interpretational injection of ethanolic extract of N. septemcrenata on plasma total antioxidant capacity (percentage) of rat is presented in table (10).

Table 7: Effect of interperitoneal injection of ethanolic extract of Nepetaseptemcrenatawith two doses (1/5 LD50& 1/10 LD50) on Blood glutathione content (mg/dl) of rat.

Time Period Control Treatment
1/5 LD50 %of change 1/10 LD50 % of change
2hours 1152.23±1.85a 2150±24.6* +86.59 1859.25±12.1678 +61.36
4hours 1155.55±7.40 +0.28 1156.70±2.94 +0.38
8hours 1193.66±27,42 +3.59 1312.79+27,48 +13,93
16hours 1404.86±23.79* +21.92 1375.8±27.48 +19.40
24hours 1170.95±4.74* +1.62 1504.93±58.92* +30.61

Table 8: Effect of interperitoneal injection of ethanolic extract of Nepetaseptemcrenatawith two doses (1/5 LD50& 1/10 LD50) on Blood catalase activity (µ/ml) of rat.

Time period Control Treatment
1/5 LD50 % of change 1/10 LD50 % of change
2hours 10.8±1.98a 19.8±1.98* +83.33 16.20±1.105 +50
4hours 14.4±1.29 +33.33 21.6±2.7* +100
8hours 23.4±1.43* +116.6 26.64+1.41* +146.66
16hours 37.8±1.58* +250 25.75±2.88* +138.33
24hours 21.6±2.60* +100 28.26±3.0* +161.66

Table 9: Effect of interperitoneal injection of ethanolic extract of Nepetaseptemcrenatawith two doses (1/5 LD50& 1/10 LD50) on (Cu/Zn) superoxide dimustase activity (µ/ml blood)of rat.

Time period Control Treatment
1/5 LD50 % of change 1/10 LD50 % of change
2hours 22.5± 2.3a 32.61±2.5* +44.93 72.79±2.80* +223.51
4hours 50.72±4.81* +125.42 50.89±5.90* +126.17
8hours 90.17±7.27* +300.75 139.98+9.87* +522.13
16hours 109.34±4.71* +385.95 74.63±3.18* +231.68
24hours 78.52±4.21* +248.97 81.22±2.57* +260.97

Table 10: Effect of interperitoneal injection of ethanolic extract of Nepetaseptemcrenatawith two doses (1/5 LD50& 1/10 LD50) on (Cu/Zn) superoxide dimustase activity (µ/ml blood)of rat.

Time period Control Treatment
1/5 LD50 % of change 1/10 LD50 %of change
2hours 66.45±.52a 66.73±0.5* +0.42 79.66±1.7* +19.88
4hours 68.52±3.3* +3.11 78.43±1.95* +18.03
8hours 68.085±1.95* +2.46 91.6±3.05* +37.84
16hours 84.63±2.29* +27.35 72.18±3.42* +8.62
24hours 95.43±1.05* +45.61 69.16±4.32* +4.08

DISCUSSION

In recent decades, interest in natural products has been restored by discovering penicillin, plant- derived tranquilizers, and plant precursors of cortisone. Contrary to previous beliefs, botanical drugs are proving more economical than synthetics, and hold forth encouraging prospects of inhibiting or destroying tumor without undue damage to healthy tissue. Extensive plant screening programs are being conducted by governmental agencies and pharmaceutical companies. Folk remedies, still common in many tropical areas, are being evaluated. No ways the general public is being made aware that herbal drugs are not obsolete but offer new hope for conquering disease [21].

Medicinal plants (also known as herbs, herbal medicine, pharmacologically active plants and phytomedicinaks) are the dominant form of medicine in most countries. More than three-fourth of the current population depend on raw products to meet daily health care needs22. Approximately 25% of the drugs available in the average American pharmacy come from plants, either as purified extracts or as partially modified secondary products [23].

Intraperitoneal LD50 of alcoholic Nepetaseptemcrenata extract was estimated and it was found to be 1009.58 mg/kg body weight for mice and 504, 79 mg/kg body weight for rats. This results in agreement with [5] who reported that the alcoholic extract of N.septemcrenata have a wide marginal safety where it's LD50 was 421.8 mg/kg body weight in rat. Also this value was a bit close to the LC59 of Nepetacataria recorded by [24]. They mentioned that intraperitoneal LD50 of Nepetacataria oil, nepetalactoneenriched fraction and nepetalic acid were found in mice to be 1300 mg/kg, 1550 mg/kg and 1050 mg/kg, respectively.

1Estimated the chemical components of the aerial parts of Nepeta sintenisii. The plant subjected to hydrolysis and the chemical composition of the isolated essential oil was analyzed by GC/MS method for the first time. Forty constituents (96.5% of the total oil) were identified. 3neepetalactone (23.4%), elemo (16.1%), E- 3-famesene (9.5%), 1.8-cineole (8.2%), cissabinene hydrate (6.5%), 3-bisabolene (4.2%) and germacrene-D(3.5%) were the main components.

Importance of Nepetaspecies as medicinal herb is due to its contents of flavinoides. Different classes of flavonoides were previously extracted and identified from many species of genus Nepeta [9]. The isolation and identification of various flavonols inNepetanepetalla were reported by 25. The identification of rosmarinic, ferulic, pcoumarric and p-hydroxybenzoic acids in the leaves and flowers of Nepetanepetellaand N. tuberose, and caffeic acid in N. nepetella, is described by [26]. In addition [27] isolated and identified the phenolic acids from the stems of Nepetanepetella subspecies cordifolia (Willk) and Nepetatuberose subspecies reticulate. The stem contains fewer phenolic acids than the leaves and flowers. The following compounds were identified, caffeic, syringic, 4-hydroxybenzoic (phydroxybenzoic acid), vanillic, cis-pcoumaric and trans-p-coumaric acids.

Both external and lipophilic aglycones as well as vascular glycosides of the air dried aerial part of N. transcauasica were studied [5] stated that, the compounds were identified as: crisimaritin (L VIII), xanthomicrol (LIX), salvigenin (LX), gardenin-B(LXL), apigenin and genkwanin (LXII), and as external aglycones while luteolin, apigenin (LXIII), 7-glucouronides (LXIV), nepetin and hispidulin-glucosided (LXLL), nepetin and hispidulin-7- glucosided (LXV) and 7-glucouroindes (LXVI) as avascular glycoside.

2Reported the results of phytochemical studies on aerial parts of Nepetasibthorpii, an endemic plant of Greek, the bioassay- guided fractionation of methanol extract led to the isolation of ursolic acid and polyphenol fraction by HPLC. They determined some phenolics: chlorogenic acid (0.315 mg/g) and the flavonoids rutin (0.09mg/g), luteolin-7-oglucoside (0.387 mg/g) and a luteoin derivative. They assayed the radical scavenging activity of Nepetasibthorpii methanol extract by the 1, 1-dipheny 1-2- picrylhydrazyl (DPPH).

It was found that apigenin as flavonoid of Nepetaseptemcrenata extract inhibits the induction of β- galactosidase. Apignin demonstrated potent antiinflammatory activity in carrageenan included rat paw edema and it was concluded that flavonoids offer important therapeutic potential for the treatment of a variety of inflammatory diseases28. It was investigated that the bioflavonoids on lysosmal acid hydrolylases, viz., β-N-acetyl glucosaminidase and cathepsinn D in serum, liver, kidney and spleen and the stability of liver lysosomes was studied by [29]. The activity of these enzymes in arthritic tissue and serum increased significantly. The total activity of β-glucurandase in the lysosomerich fraction from arthritic liver was appreciably decreased, while its release was significantly increased. It was found that one of the most potent flavones, apigenin as a flanonoid exhibited a dose-and timedepentent, reversible effect on adhesion protein expression as well as inhibitory adhesion protein up regulating at the transcriptional leve l0 [28]. Also, apigenin inhibited 1L-1α-induced prostaglandin synthesis and TNF-a- induced 1L-6 and 1L- 8 productions, suggesting that the hydroxyl flavones may acts as general inhibitors of cytokine-induced gene expression. As well as, this falconoid inhibit TNF-α induced β- glactosiddase activity in SW 480 cells stably transected will a β-glactosiddase.

It was found that the natural extract of some medicinal plants protect free radicals damage [30]. In addition, it has been shown that the content of the mucosal non protein. Sulfhydrxyl group may increase by the effect of the active ingredients of the medicinal plants [31]. It was found that protective effects of four flavonoids "quercetin, rutin, luteolin and apigenin" against induced DNA damage in human leukemia cells (K562). These flavonodis are characterized by the number of hydroxyl groups on the B ring, the presence of an Odihydroxy structure on the B-ring confers a higher degree of stability to the flavonoid phenoxyl radicals by participating in electron delocalization and is, therefore, an important determinant for antioxidant potential [32]. The strongest inhibition against DNA damage (44%, 42%) was found in a range of luteolin and quercetin concentrations of 20-100 u mol/L. It has been investigated that DNA protective capacity of three flavonoids, apigenin, luteolin and quercetin against the free radical generated by H2O2. The quantitative analysis has shown that luteolin possesses the highest DNA protective effect of flavonoids [33].

Also, thirteen isoflavonoids, flavonoids, and lignanshave been found to be evaluated for their effects on DNA synthesis in MCF-7 and human breast cancer cells by [34]. At 0.1-10 μM of coumestrol, genistein, biochaninA, luteolin, apigeninkaempferol and enterolactone induced DNA synthesis 150-235% and at 20-90 Um, inhibited DNA synthesis at high concentrations but induction at concentration close to probable levels in humans. [35] Investigated that the flavonoides "qurestin, rhamnetin, isorhamnetin, apigenin, and luteolin" did not introduce any damage into the DNA.

In conclusion, N. septemcrenata has many promising active constituents that exert significant pharmacological and therapeutic effects with high margin of safety. We recommend further phytochemical and pharmacological studies on each purified active constituent of this plant on different body systems and on fatal diseases such as cancer and AIDS.

REFERENCES

  1. Sajjadi S. Analysis of Essential Oil of NepetaSintenisii Bornm from Iran. Journal of Faculty of Pharmacy-  Teheran-University- of- Medical- Sciences, 2005; 13 (2): 61-64.
  2. Miceli N., Taviano M., Giuffreda D., Trovate A. and Galati E. Anti- Inflammatory Activity of Extract Fractions from NepetaSibthorpii Bentham. J- Ethnopharmacol., 2005; 97(2): 261-266.
  3. Arnold N., Bellomaria, G., Volentriri G., Yanninou C., and Arnald H. J. Plantes Medicinales-Et-Phytotherpie, 1993; 26 (1):52-63.
  4. Pagni A. M., Catalano P. I. and Morelli. Plants Medicinal- Et- Phytotherpie, 1990; (24): 3, 203-213.
  5. Abdel-Shafiq K. A. Chemical Studies on Certain Plants of Family Labiate. M.Sc. Thesis, Chemistry Dep. Faculty of Science, Cairo University. 1997; Pp.174.
  6. Khalil, A.T., Gedarasr, Lahoub, M.F., Halim, A.F. and Voehler, M. Aditrepene from NepetaSeptemcrenata. Phytochemistry, 1997; 44 (3): 475-478.
  7. El-Hamouly A. M., and El-Hela A. A. Phytochemical and Biological Investigation of The Volatile Constituents Of NepetaSeptemcrenata Ehrenb., Growing in Egypt. Bull-Pharm-Sci-Assiut-Univ., 2004; 27(6):95-98.
  8. Sherry C. And Mitchell J. Behavioral Effect of the Lactone-Free Hot Water Extract of Catnip (NepetaCataria) on the Young Chick. Int-J-Crude-Drug-Res., 1983; 21(8):89-92.
  9. Saker M. M. And Kawashity S. A. Tissue Culture and Flavonoid Content of Nepeta and Plantago Species Endemic in Egypt. Fitoterapia., Lxix (4), 1998; 358-364
  10. He-R., Liu-B. Q., And Zhong H. L. Coparative Study Of The Preparation of Jingfang Oral Liquid With Clarificant And Precipitant. Chinese-Traditional-And-Herb Al-Drug, 1998; 29 (11):734-735.
  11. Aydin S., Demir T., Ozturk Y. and Baser K. (1999).Analgesic activity of Nepeta italic L. phytother Res. 13(1):20-23.
  12. Maral J., Puget, K. and Michelson A M. Comparative Study of Superoxide Dismutase, Catalase and Glutathione Peroxidase Levels In Erythrocytes of Different Animals. Biochem. Biophys. Res. Common., 1977; 77:1525-1535.
  13. Winterbourn C. C., Hawkins R. E, Brian M, and Carrell R W. The Estimation of Red Cell Superoxide Dismutase Activity. J. Lab. Clin. Med., 1974; 85: 337-342.
  14. Tanaka K., And Lizuka Y., Suppression of Enzyme ReleaswFrom Isolated Rat Liver Lysosomes by Non-Steriodal Anti- inflamatory Drug. Biochem. Pharmcol., 1968; 17(10)2023-2032 .
  15. Younan E A. Personal Communication to Becknmeyer B., Biol. Chem., 1972; 263:17205-17208.
  16. Younan E. A. and Rosleff F. Changes of Lysosomal Enzymatic Activities in Human Skin Fibroblasts at Various Passages. J. Drug. Res., Egypt, 1974; 6(3): 137-137.
  17. Schmidt G. And Thannhauser S. J., Amethod for The Determination of Deoxyribonucleic Acid and Phsphoporoteins in Animal Tissues. J. Biol. Chem., 1945; 161:83-89.
  18. Daughaday W. H., Lowry G. H, Rosebrough Harney J.W., Barofsky I.M. and Leary L.D. (1978). Behavioral and toxicological studies of cyclopentanoidmonoterpenes from Nepetacataria. Lloydia. 41(4): 367-374.
  19. Bermejo B. P., and Serranillos F. M. Contri- Bution to The Study of Flavonol Compounds in Nepeta Nepetella (L.) (Labiatae). Anales-De-La-Real-Academia- De-Farmacia., 1984; 50 (3): 459-463.
  20. Saez E., Rodriguez M. And Bermejo P. Contributions to the Study of Phenolic Acids in Nepeta L. (Labiata) Species. Anales-De- La-Real-Acadmia-De-Farmacia., 1985; 52(1):597-603.
  21. Saez E., Rodriguez M., and Bermejo P. Phenolic Acid from Two Species of Nepeta L. (Labiatae). Part2. Stems. Anales-De-La- Real-Academia., 1986; 52 (1): 113-116.
  22. Gerritsen, M. E., Carley W. W., Ranges G. F., Shen, C. P., Phan S. A., Ligon G. F. And Perry C. A. Flavonoids Inhibit Cytokine Induced Endothelial Cell Adhesion Protein Gene Expression. Amj. Pathol., 1995; 147 (2): 235-237.
  23. Rao C. N., Rao V. H., Verbuggen L. and Orloff S. Effect of Bioflavonoids on Lysosomal Acid Hydrolylases and Lysosomal Stability in Adjuvant-Induced Arthritis. Scand J. Rheumatol., 1980; 9(4):280-284.
  24. Calabrese V., Scapagnini G., Catalano C., Dinotta F., Geraci D. and Morganti P. Biochemical Studies of A Natural Antioxidant Isolated From Rosemary and Its Application In Cosmetic Dermatology. Int. J. Tissue React., 2000; 22 (1): 5-13.
  25. Dias P., Foglio M. A., Possenti A. and De Carvalho J. E. Antiulcerogenic Activity of Crude Hydroalcoholic Extract of Rosmarinus Officinalis. L. J. Ethnopharmacol., 2000; 69:57-57.
  26. Horvathova, K., Novotny L., Tothova D. and Vachalkova A. Determination of Free Radical Scavenging Activity Of Quercetin, Rutin, Luteolin and Apigenin In H2o2 – Treated Human Ml Ulls K562. Neoplasma, 2004; 51(5):135-141.
  27. Ramanova D., Vachalkova A., Cipak L., Ovesna Z., And Rauko P. Study of Antioxidant   of   Apigenin,   Luteolin  and Quercetin  By  Dna  Protective  Method. Neoplasma, 2001; 48(2): 104-107.
  28. Wang C. and Kurzer M. S. Phytoestrongen Concentration Determines Effect of DNA Synthesis In Human Breast Cancer Cells. Nutr Cancer, 1997; 28 (3):236-247.
  29. Czeczot H. and Kusztelak J. A Study of TheGenotoxic Potential of Flavonoides Using Short-Term Bacterial Assays. Acta. Biochem. Pol., 1993; 40 (4):549-554.
  30. N. J. and Fields W. S. Determination of Cerebrospinal Fluid Protein With Folin Phenol Reagent. J. Lab. Clin. Med., 1952; 39:663-663
  31. Dische Z., Chargaff E. And Davidson I. N. In "The Nucleic Acids" (Eds). Academic Press. New York., 1955; P. 1-1.
  32. ArmitageP., and Berry G. Comparison of Several Groups. In: Statical Methods in Medical Research 2nd Ed. Blockwell Significant Publication, Oxford. 1987; Pp.186-213.
  33. Morton J. F. Medicinal Plants-Old and New. Morton Collectanea, University of Miamiii, Coral Gables, Florida (Ed.). Presented To The Pharmacy Libraries. Group at The Sixty-Sixth Annual Meeting of The Medical Library Association Miami, Florida., 1967
  34. Akerele O. The Who Traditional Medicine Program: Policy and Implementation. International Traditional Health Newsletter, 1985; 1(1):1-1.
  35. Farnsworth N. The Role of Ethnopharmacology in Drug Development. In D. Chadwick and J. March, Eds., Bioactive Compounds From Plants, Ciba Symposium, 154. Wiley; 1990, Chichester, England.
Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article